Study Suggests Weight-Loss Pill is as Effective as Ozempic The drugs in development include a pill that a new trial suggests is about as effective as Ozempic By Dani Blum Reporting from the American Diabetes Association Scientific Sessions in Chicago
New Weight Loss Pill Rivals Ozempic: What the Data Shows Among the most anticipated newcomers is a daily pill that early data suggests could be as powerful as the popular weekly injections currently on the market Reporting from the American Diabetes Association Scientific Sessions in Chicago, new findings presented this past weekend highlight just how potent these forthcoming weight loss drugs might be
The new Ozempic? Weight-loss pill Amycretin could be more . . . A new weight-loss treatment that can be administered as either a weekly injection or a daily pill has shown promising results in early-stage trials, according to a new study In one of the trials
Eli Lilly says its anti-obesity pill matches Ozempic Eli Lilly's Orforglipron, an anti-obesity pill, demonstrated significant weight loss and blood sugar reduction in clinical trials, rivaling Novo Nordisk's Ozempic The company plans to submit Phase-III trial data to regulators by year-end, anticipating approvals from 2026 The 36 mg dose resulted in an average weight loss of 7 9% over 40 weeks